検索
Akoustis Technologies Ord Shs
AKTSウォッチリストに追加
27.050USD
+0.400+1.50%
終値 09-04 16:00（ET）
1.50B時価総額
損失額直近12ヶ月PER
詳細情報 Akoustis Technologies Ord Shs 企業名
Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.
Akoustis Technologies Ord Shs プロフィール
企業コードAKTS
会社名Aktis Oncology Inc
上場日Jan 09, 2026
最高経営責任者「CEO」Roden (Matthew)
従業員数117
証券種類Ordinary Share
決算期末Jan 09
本社所在地17 Drydock Avenue
都市BOSTON
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号02210
電話番号13026587581
ウェブサイトhttps://www.aktisoncology.com/
企業コードAKTS
上場日Jan 09, 2026
最高経営責任者「CEO」Roden (Matthew)
Akoustis Technologies Ord Shsの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Paul L. Feldman, Ph.D.
Mr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Mr. Todd Foley
Mr. Todd Foley
Chairman of the Board
Chairman of the Board
--
-100.00%
Ms. Shulamit Ron-Bigger, Ph.D.
Ms. Shulamit Ron-Bigger, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kyle D. Kuvalanka
Mr. Kyle D. Kuvalanka
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Akos Czibere, M.D.
Mr. Akos Czibere, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Ken Herrmann, M.D.
Mr. Ken Herrmann, M.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Paul L. Feldman, Ph.D.
Mr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Mr. Todd Foley
Mr. Todd Foley
Chairman of the Board
Chairman of the Board
--
-100.00%
よくある質問
Akoustis Technologies Ord Shsの上位5名の株主は誰ですか？
Akoustis Technologies Ord Shsの上位5名の株主は以下のとおりです。Mr. Matthew (Matt) Roden, Ph.D.
Akoustis Technologies Ord Shs（AKTS）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Akoustis Technologies Ord Shsの株式を保有している機関は195社あり、保有株式の総市場価値は約27.52Mで、全体の51.47%を占めています。2025Q4と比較して、機関の持ち株は1127277.00増加しています。